세계의 바이오잉크 시장 : 성장 기회, 성장 촉진요인, 산업 동향 분석과 예측(2024-2032년)

The Global Bioink Market was valued at USD 70.4 million in 2023 and is projected to grow at a CAGR of 12.5% from 2024 to 2032. This rapid growth is primarily driven by the increasing use of bioink in biomedical research therapy and the rising prevalence of chronic diseases and organ failure. The growing demand for innovative medical solutions, such as bio-printed tissues and organs, is fueling the market expansion. Advancements in 3D bioprinting technology, alongside increased collaborations between pharmaceutical companies and research institutions, also contribute to market growth. These partnerships help drive innovations in bioink formulations, enhancing their application in areas like tissue engineering and drug delivery.

The continuous evolution of bioprinting systems and the development of bioinks that are both biocompatible and versatile are expected to further accelerate market growth. The market is segmented based on bioink types into natural and synthetic categories. In 2023, the natural bioink segment led the market with a revenue of USD 60.7 million. Natural bioinks are favored due to their biocompatibility and non-toxic properties, making them suitable for tissue engineering applications.

The increasing emphasis on sustainable practices in biomedical research has further bolstered the demand for natural bioinks, as they are often derived from renewable and biodegradable sources. In terms of materials, the bioink market includes collagen, alginate, gelatin, agarose, chitosan, Pluronic, and others. Collagen emerged as the dominant material, holding a 36% market share in 2023. Its high compatibility with human tissue and its ability to form fibrous networks make collagen essential for tissue engineering and regenerative medicine. The use of collagen in various medical applications, such as wound healing and tissue repair, coupled with regulatory approvals, is expected to drive continued growth in this segment.Regionally, North America accounted for a significant 43.6% of the market in 2023. The availability of advanced bioink technologies, including improved printing resolutions and multi-material capabilities, enhances the adoption of bioink-based products in the region. Furthermore, North America benefits from a supportive regulatory environment encouraging investment in bioprinting technology, fostering further market growth.

Table of Contents

Chapter 1 Methodology & Scope

• 1.1 Market scope & definition
• 1.2 Research design
  • 1.2.1 Research approach
  • 1.2.2 Data collection methods
• 1.3 Base estimates & calculations
  • 1.3.1 Base year calculation
  • 1.3.2 Key trends for market estimation
• 1.4 Forecast model
• 1.5 Primary research and validation
  • 1.5.1 Primary sources
  • 1.5.2 Data mining sources

Chapter 2 Executive Summary

• 2.1 Industry 360° synopsis

Chapter 3 Industry Insights

• 3.1 Industry ecosystem analysis
• 3.2 Industry impact forces
  • 3.2.1 Growth drivers
    • 3.2.1.1 Rising application in regenerative medicine
    • 3.2.1.2 Increase in demand for 3D printed tissue and organs
    • 3.2.1.3 Rise in prevalence of chronic disease and organ failure
    • 3.2.1.4 Advancement in bioprinting technologies
  • 3.2.2 Industry pitfalls & challenges
    • 3.2.2.1 Stringent approval filing process
    • 3.2.2.2 High manufacturing cost
• 3.3 Growth potential analysis
• 3.4 Regulatory landscape
• 3.5 Future market trends
• 3.6 Technological advancements
• 3.7 GAP analysis
• 3.8 Porter's analysis
• 3.9 PESTEL analysis

Chapter 4 Competitive Landscape, 2023

• 4.1 Introduction
• 4.2 Company market share analysis
• 4.3 Company matrix analysis
• 4.4 Competitive analysis of major market players
• 4.5 Competitive positioning matrix
• 4.6 Strategic dashboard

Chapter 5 Market Estimates and Forecast, By Type, 2021 - 2032 ($ Mn)

• 5.1 Key trends
• 5.2 Natural bioink
• 5.3 Synthetic bioink

Chapter 6 Market Estimates and Forecast, By Material, 2021 - 2032 ($ Mn)

• 6.1 Key trends
• 6.2 Collagen
• 6.3 Alginate
• 6.4 Gelatin
• 6.5 Agarose
• 6.6 Chitosan
• 6.7 Pluronic
• 6.8 Other materials

Chapter 7 Market Estimates and Forecast, By Application, 2021 - 2032 ($ Mn)

• 7.1 Key trends
• 7.2 Tissue engineering
• 7.3 Medical application
• 7.4 Drug discovery & delivery
• 7.5 Other applications

Chapter 8 Market Estimates and Forecast, By Printing Modality, 2021 - 2032 ($ Mn)

• 8.1 Key trends
• 8.2 Extrusion based bioprinting
• 8.3 Ink-jet based bioprinting
• 8.4 Laser-based bioprinting

Chapter 9 Market Estimates and Forecast, By End Use, 2021 - 2032 ($ Mn)

• 9.1 Key trends
• 9.2 Pharmaceutical & biotechnology companies
• 9.3 Academic & research institutes
• 9.4 Hospitals and clinics
• 9.5 Other End Use

Chapter 10 Market Estimates and Forecast, By Region, 2021 - 2032 ($ Mn)

• 10.1 Key trends
• 10.2 North America
  • 10.1.1 U.S.
  • 10.1.2 Canada
• 10.2 Europe
  • 10.2.1 Germany
  • 10.2.2 UK
  • 10.2.3 France
  • 10.2.4 Italy
  • 10.2.5 Spain
  • 10.2.6 Netherlands
  • 10.2.7 Rest of Europe
• 10.3 Asia Pacific
  • 10.3.1 China
  • 10.3.2 Japan
  • 10.3.3 India
  • 10.3.4 Australia
  • 10.3.5 South Korea
  • 10.3.6 Rest of Asia Pacific
• 10.4 Latin America
  • 10.4.1 Brazil
  • 10.4.2 Mexico
  • 10.4.3 Rest of Latin America
• 10.5 Middle East and Africa
  • 10.5.1 South Africa
  • 10.5.2 Saudi Arabia
  • 10.5.3 UAE
  • 10.5.4 Rest of Middle East and Africa

Chapter 11 Company Profiles

• 11.1 Allevi, Inc. (3D Systems)
• 11.2 Axolotl Biosciences
• 11.3 BIO INX
• 11.4 CELLLINK (BICO)
• 11.5 CollPlant Biotechnologies Ltd
• 11.6 Foldink
• 11.7 Gelomics
• 11.8 INNOREGEN, Inc.
• 11.9 Merck KGaA
• 11.10 Rokit Healthcare
• 11.11 TheWell Bioscience Inc.
• 11.12 UPM Biomedicals
• 11.13 Viscient Biosciences
• 11.14 VoxCell BioInnovation Inc.